Murae Organisor Ltd.

View in App
1.66 -0.03 ▼-1.8%

19 April 2024, 03:16:00 PM
Volume: 265,069

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.earumpharma.com
Market Cap 41.02 Cr.
Enterprise Value(EV) 44.28 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.03 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.01 Trailing Twelve Months Ending 2023-12
Book Value / Share 2.21 Trailing Twelve Months Ending 2023-12
Price to Book Value 0.75 Calculated using Price: 1.66
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 24.71 Cr. 247,111,618 Shares
FaceValue 2
About Murae Organisor Ltd.
The company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. Apart from pharmaceutical formulation products, it also deals in trading of active pharmaceutical ingredients (API's) such as Levofloxacin Hemihdrate IP, Albendazol IP, Amoxicillin Trihydrate IP etc.

Murae Organisor Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Murae Organisor Ltd. Performance

View details >>
1 Day
-1.78%
1 Week
-8.29%
1 Month
-9.78%
3 Month
-2.92%
6 Month
+66.00%
1 Year
-27.83%
2 Year
-72.33%
5 Year
10 Year

Murae Organisor Ltd. Fundamental Ratios

View details >>
8 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 7.15 11.05 30.94 32.17 17.83 0.61 14.24 11.18
Return on Capital Employed (%) 17.1 21.97 24.94 23.99 17.4 4.23 12.34 11.66
Return on Assets (%) 1.11 1.61 5.98 7.77 6.11 0.28 7.85 6.91

Murae Organisor Ltd. Balance Sheet

View details >>
Particulars 9 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 1 2 5 6 14 15 17 19 55
Non Curr. Liab. 0 1 2 3 1 2 0 0 0
Curr. Liab. 7 9 13 15 20 11 12 10 6
Minority Int.
Equity & Liab. 9 11 20 23 36 28 29 29 60
Non Curr. Assets 0 0 0 0 4 1 1 0 0
Curr. Assets 9 11 19 23 32 27 28 28 60
Misc. Exp. not W/O
Total Assets 9 11 20 23 36 28 29 29 60

Murae Organisor Ltd. Profit and Loss

View details >>
Particulars 9 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 19 23 35 51 55 41 21 14 4
Other Income 0 0 0 0 2 9 8 2 1
Total Income 19 24 36 51 57 50 29 16 5
Total Expenditure -18 -23 -34 -47 -54 -49 -25 -13 -4
PBIDT 1 1 2 3 4 1 3 3 0
Interest 0 -1 -1 -1 -1 -1 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 -1 -1 0 -1 -1 -1
Exceptional Items
PAT 0 0 1 2 2 0 2 2 -1
Adjusted EPS 0 0 0 0 0 0 0 0

Murae Organisor Ltd. Cash Flow

View details >>
Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -7 0 -3 -7 3 0
Cash Fr. Inv. 0 0 0 0 -3 3 0
Cash Fr. Finan. 1 0 7 1 7 3 -3 0
Net Change 0 0 0 0 0 -1 0 0
Cash & Cash Eqvt 0 0 0 0 0 -1 0 0

Murae Organisor Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 50.21 37.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Public 49.79 62.43 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Murae Organisor Ltd. Announcements

View details >>
Thu, 18 Apr 2024
Addendum To Notice Of The Extra Ordinary General Meeting Of Murae Organisor Limited (Formerly Known As Earum Pharmaceuticals Limited) Scheduled To Be Held On Wednesday 24Th April 2024 At 2:00 P.M. Through Video Conferencing (VC) / Other Audio-Visual Means (OAVM)
Addendum to Notice of EGM of Murae Organisor Limited to be held on Wednesday 24th April 2024 at 2:00 P.M. through VC/OAVM.
Mon, 15 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Submission of Certificate under Regulation 74(5) of SEBI (Depository and Participant) Regulation 2018 for the quarter ended on 31st March 2024
Thu, 04 Apr 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement for Notice of Extra-Ordinary General Meeting of the Company under the Regulation 47 of SEBI (LODR) Regulation 2015 as per attachment

Murae Organisor Ltd. Technical Scans

View details >>
Thu, 18 Apr 2024
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Opening at High Opening at High
Opening at Low Opening at Low

Murae Organisor Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,015.10 1,522.95 +0.4%
Cipla Ltd. 108,808.58 1,344.75 -0.2%
Dr. Reddy's Laboratories Ltd. 99,408.67 5,957.90 +0.0%
Divi's Laboratories Ltd. 98,683.96 3,665.30 -1.2%
Mankind Pharma Ltd. 96,037.07 2,339.75 -2.3%
Zydus Lifesciences Ltd. 94,213.69 924.20 -1.4%
Apollo Hospitals Enterprise Ltd. 87,250.69 6,151.00 +1.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.87 1,522.95 +0.4%
Cipla Ltd. Consolidated 2023-12 29.34 1,344.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.01 5,957.90 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 71.36 3,665.30 -1.2%
Mankind Pharma Ltd. Consolidated 2023-12 55.61 2,339.75 -2.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.68 924.20 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 110.54 6,151.00 +1.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.83 1,522.95 +0.4%
Cipla Ltd. Consolidated 2023-12 4.20 1,344.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,957.90 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.57 3,665.30 -1.2%
Mankind Pharma Ltd. Consolidated 2023-12 10.81 2,339.75 -2.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.00 924.20 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 12.92 6,151.00 +1.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,522.95 +0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,344.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,957.90 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,665.30 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,339.75 -2.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 924.20 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,151.00 +1.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,522.95 +0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,344.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,957.90 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,665.30 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,339.75 -2.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 924.20 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,151.00 +1.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,522.95 +0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,344.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,957.90 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,665.30 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,339.75 -2.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 924.20 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,151.00 +1.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,522.95 +0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,344.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,957.90 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,665.30 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,339.75 -2.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 924.20 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,151.00 +1.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,522.95 +0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,344.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,957.90 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,665.30 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,339.75 -2.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 924.20 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,151.00 +1.3%

Murae Organisor Ltd. FAQ's

What is Murae Organisor share price?
Can I buy Murae Organisor shares now?
What is the Market Cap of Murae Organisor?
What are the key metrics to analyse Murae Organisor?
What is the 52 Week High and Low of Murae Organisor?
What is the trend of Murae Organisor share price?